Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELEVATE 1: Rodatristat ethyl in PAH
NCT03924154Phase 2Terminated
- Sponsor
- Altavant Sciences
- Start
- Aug 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of rodatristat in pulmonary arterial hypertension (PAH), sponsored by Altavant Sciences. Started Aug 2019; status: terminated.
02
Drugs
rodatristat
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03924154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03924154.